Report
EUR 168.93 For Business Accounts Only

Moody's assigns Ba2/Aa2.br to Grupo Fleury's proposed BRL 500 million debentures

Rating Action: Moody's assigns Ba2/Aa2. br to Grupo Fleury's proposed BRL 500 million debentures. Global Credit Research- 21 Nov 2019. Sao Paulo, November 21, 2019-- Moody's America Latina has assigned Ba2/Aa2. br ratings to Fleury S.A.' s proposed BRL 500 million senior unsecured debentures with series due in 2024 and 2027. The outlook for the rating is stable.
Underlying
Fleury SA

Fleury SA, formerly Laboratorio de Analises e Pesquisas Clinicas SC Ltda, is a Brazil-based company engaged in the provision of medical laboratory services. The Company's activities are divided into three business segments: Diagnostic medicine, Integrated medicine and Dental. The Diagnostic medicine division provides clinical analysis and diagnostic imaging in partner hospitals. The Integrated medicine division offers private medical diagnostics, as well as tests for laboratories, hospitals and clinics. The Dental division focuses on dental diagnostic imaging. The Company provides services in Brazil through a number of brand names, such as Fleury, Felippe Mattoso, Weinmann, a+ Medicina Diagnostica, Labs a+, Diagnoson a+ and Papaiz.

Provider
Moody's Investors Service
Moody's Investors Service

Moody's Investors Service is a leading provider of credit ratings, research, and risk analysis. Moody's commitment and expertise contributes to transparent and integrated financial markets, protecting the integrity of credit. Our ratings and analysis track debt covering more than:

  • 130 countries
    11,000 corporate issuers
    21,000 public finance issuers
    76,000 structured finance obligations



Credit ratings and research help investors analyze the credit risks associated with fixed-income securities. Such independent credit ratings and research also contribute to efficiencies in fixed-income markets and other obligations, such as insurance policies and derivative transactions, by providing credible and independent assessments of credit risk.



Moody’s default studies validate our predictive ratings. Our published research and investor briefings draw thousands of attendees each year and keep investors current with the rationale underlying our credit opinions. 

Other Reports on these Companies
Other Reports from Moody's Investors Service

ResearchPool Subscriptions

Get the most out of your insights

Get in touch